These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 19799143)
21. Japanese encephalitis: development of new candidate vaccines. Bharati K; Vrati S Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211 [TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia. Liu W; Clemens JD; Kari K; Xu ZY Vaccine; 2008 Aug; 26(35):4456-60. PubMed ID: 18602436 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China. Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051 [TBL] [Abstract][Full Text] [Related]
24. [Analysis on data from the clinical acute viral encephalitis surveillance system in three prefectures in Shaanxi during 2005 - 2006]. Zhang SB; Yin ZD; Suraratdecha C; Hills SL; Liu XZ; Li YX; Xia XQ; Liang GD; Liang XF Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):895-8. PubMed ID: 19173854 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology and burden of disease from Japanese encephalitis in Cambodia: results from two years of sentinel surveillance. Touch S; Hills S; Sokhal B; Samnang C; Sovann L; Khieu V; Soeung SC; Toda K; Robinson J; Grundy J Trop Med Int Health; 2009 Nov; 14(11):1365-73. PubMed ID: 19747185 [TBL] [Abstract][Full Text] [Related]
26. [The progress and challenge of Japanese encephalitis control and prevention in China]. Wang HY Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Feb; 53(2):133-135. PubMed ID: 30744284 [TBL] [Abstract][Full Text] [Related]
27. Japanese encephalitis in mainland china. Wang H; Li Y; Liang X; Liang G Jpn J Infect Dis; 2009 Sep; 62(5):331-6. PubMed ID: 19762980 [TBL] [Abstract][Full Text] [Related]
28. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus. Okamoto S; Yoshii H; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y Vaccine; 2008 Jan; 26(5):589-94. PubMed ID: 18180081 [TBL] [Abstract][Full Text] [Related]
29. Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China. Hu XT; Li QF; Ma C; Zhao ZX; He LF; Tang TT; Yu W; Owiti P Infect Dis Poverty; 2019 Dec; 8(1):102. PubMed ID: 31818328 [TBL] [Abstract][Full Text] [Related]
30. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses. Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743 [TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial. Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Sabchareon A; Pancharoen C; Bouckenooghe A; Gailhardou S; Boaz M; Feroldi E Pediatr Infect Dis J; 2010 Dec; 29(12):1111-7. PubMed ID: 20856164 [TBL] [Abstract][Full Text] [Related]
32. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Hegde NR; Gore MM Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270 [TBL] [Abstract][Full Text] [Related]
33. [A survey of Japanese encephalitis antibody migrant workers in Shenzhen 2009]. Shan FX; Cheng JQ; Mou J; Zhang SY; He YQ; Xiao JH; Chen YJ; Huang WG; Xiong LE Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Sep; 44(9):806-9. PubMed ID: 21092624 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study. Muangchana C; Henprasertthae N; Nurach K; Theppang K; Yoocharoen P; Varinsathien P; Techathawat S; Sanohsieng S; Anantapreecha S Vaccine; 2012 Jan; 30(2):361-7. PubMed ID: 22075090 [TBL] [Abstract][Full Text] [Related]
35. A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis. Lyons A; Kanesa-thasan N; Kuschner RA; Eckels KH; Putnak R; Sun W; Burge R; Towle AC; Wilson P; Tauber E; Vaughn DW Vaccine; 2007 Apr; 25(17):3445-53. PubMed ID: 17241714 [TBL] [Abstract][Full Text] [Related]
36. Japanese encephalitis for a reference to international travelers. Oya A; Kurane I J Travel Med; 2007; 14(4):259-68. PubMed ID: 17617849 [TBL] [Abstract][Full Text] [Related]
37. Japanese encephalitis revisited. Diagana M; Preux PM; Dumas M J Neurol Sci; 2007 Nov; 262(1-2):165-70. PubMed ID: 17643451 [TBL] [Abstract][Full Text] [Related]
38. Adults in Northwest China experienced the largest outbreak of Japanese encephalitis in history 10 years after the Japanese encephalitis vaccine was included in the national immunization program: A retrospective epidemiological study. Zhang X; Jin N; Tu A; Dong M; Shi T; Ren X; Liu S; Zhao X; Liu J; Wu Z; Li Y; Wu D; Wang H; Wang H; Hu Y; Zhang B; Wang W; Meng L J Med Virol; 2023 May; 95(5):e28782. PubMed ID: 37212323 [TBL] [Abstract][Full Text] [Related]
39. [Surveillance on Japanese encephalitis in Henan province, 2006 - 2010]. Tang XY; Kang K; Li XL; Chen HM; Xu BL Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1128-30. PubMed ID: 22336549 [TBL] [Abstract][Full Text] [Related]
40. [Effect of cytoxan on immune response of Japanese encephalitis virus killed and live vaccines]. Fang QA; Chen BQ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):317-21. PubMed ID: 2561510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]